Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

doi:10.5005/jp-journals-10018-1424

Editorial

. 2024 Jan-Jun;14(1):1-4.

doi: 10.5005/jp-journals-10018-1424.

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Shivaram P Singh¹, K C Sudhamshu², Prajna Anirvan¹, Ananta Shrestha³, Mamun Al Mahtab⁴

Affiliations

¹ Department of Translational Research, Kalinga Gastroenterology Foundation, Cuttack, Odisha, India.
² Department of Hepatology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal.
³ Department of Hepatology, Alka Hospital, Kathmandu, Nepal.
⁴ Department of Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

PMID: 39022204
PMCID: PMC11249896
DOI: 10.5005/jp-journals-10018-1424

Editorial

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Shivaram P Singh et al. Euroasian J Hepatogastroenterol. 2024 Jan-Jun.

. 2024 Jan-Jun;14(1):1-4.

doi: 10.5005/jp-journals-10018-1424.

Authors

Shivaram P Singh¹, K C Sudhamshu², Prajna Anirvan¹, Ananta Shrestha³, Mamun Al Mahtab⁴

Affiliations

¹ Department of Translational Research, Kalinga Gastroenterology Foundation, Cuttack, Odisha, India.
² Department of Hepatology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal.
³ Department of Hepatology, Alka Hospital, Kathmandu, Nepal.
⁴ Department of Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

PMID: 39022204
PMCID: PMC11249896
DOI: 10.5005/jp-journals-10018-1424

Abstract

How to cite this article: Singh SP, Sudhamshu KC, Anirvan P, et al. Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name? Euroasian J Hepato-Gastroenterol 2024;14(1):1-4.

Keywords: Alcohol; Fatty liver disease; Nomenclature; Prevention; South Asia; Steatotic liver disease; Stigma.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: Dr. Ananta Shrestha and Dr. Mamun Al Mahtab are associated as the Editorial board members of this journal and this manuscript was subjected to this journal's standard review procedures, with this peer review handled independently of these Editorial board members and their research group.

Cited by

MASLD, MLA Pesarattu and Other Developments.
Anand AC. Anand AC. J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102465. doi: 10.1016/j.jceh.2024.102465. Epub 2024 Nov 22. J Clin Exp Hepatol. 2025. PMID: 39720265 No abstract available.

References

1. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861. doi: 10.1016/s2468-1253(22)00165-0. - DOI - PubMed
1. Wang D, Xu Y, Zhu Z, et al. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Front Nutr. 2022;9:1047129. doi: 10.3389/fnut.2022.1047129. - DOI - PMC - PubMed
1. Chen H, Zhan Y, Zhang J, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: An analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12):e34809. doi: 10.2196/34809. - DOI - PMC - PubMed
1. Blais P, Husain N, Kramer JR, et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015;110(1):10–14. doi: 10.1038/ajg.2014.134. - DOI - PubMed
1. Alexander M, Loomis AK, Fairburn–Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi: 10.1186/s12916-018-1103-x. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Australian Centre for Disease Control
- PubMed Central

[1] Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861. doi: 10.1016/s2468-1253(22)00165-0. - DOI - PubMed

[2] Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861. doi: 10.1016/s2468-1253(22)00165-0. - DOI - PubMed

[3] Wang D, Xu Y, Zhu Z, et al. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Front Nutr. 2022;9:1047129. doi: 10.3389/fnut.2022.1047129. - DOI - PMC - PubMed

[4] Wang D, Xu Y, Zhu Z, et al. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Front Nutr. 2022;9:1047129. doi: 10.3389/fnut.2022.1047129. - DOI - PMC - PubMed

[5] Chen H, Zhan Y, Zhang J, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: An analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12):e34809. doi: 10.2196/34809. - DOI - PMC - PubMed

[6] Chen H, Zhan Y, Zhang J, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: An analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12):e34809. doi: 10.2196/34809. - DOI - PMC - PubMed

[7] Blais P, Husain N, Kramer JR, et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015;110(1):10–14. doi: 10.1038/ajg.2014.134. - DOI - PubMed

[8] Blais P, Husain N, Kramer JR, et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015;110(1):10–14. doi: 10.1038/ajg.2014.134. - DOI - PubMed

[9] Alexander M, Loomis AK, Fairburn–Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi: 10.1186/s12916-018-1103-x. - DOI - PMC - PubMed

[10] Alexander M, Loomis AK, Fairburn–Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi: 10.1186/s12916-018-1103-x. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Affiliations

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources